60 related articles for article (PubMed ID: 12893130)
1. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
[TBL] [Abstract][Full Text] [Related]
2. A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential 'culprit' for the tramadol 'abuse crisis'.
Thomford NE; Abraham SA; Nyarko SB; Biney RP
BMC Med Genomics; 2024 Jan; 17(1):28. PubMed ID: 38254077
[TBL] [Abstract][Full Text] [Related]
3. Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials.
Zebala JA; Searle SL; Webster LR; Johnson MS; Schuler AD; Maeda DY; Kahn SJ
J Pain; 2019 Oct; 20(10):1218-1235. PubMed ID: 31005596
[TBL] [Abstract][Full Text] [Related]
4. Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain.
Casajús A; Zubiaur P; Alday E; Soria-Chacartegui P; Saiz-Rodríguez M; Gutierrez L; Aragonés C; Campodónico D; Gómez-Fernández A; Navares-Gómez M; Villapalos-García G; Mejía-Abril G; Ochoa D; Abad-Santos F
Clin Transl Sci; 2024 Jan; 17(1):e13698. PubMed ID: 38140786
[TBL] [Abstract][Full Text] [Related]
5. Transient depersonalisation/derealisation syndrome from tramadol.
Thumtecho S; Wainipitapong S; Tantakitti P
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37280010
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease.
Mapira NL; Thelingwani RS; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 May; 24(7):359-369. PubMed ID: 37248824
[No Abstract] [Full Text] [Related]
7. The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity.
Dinh JC; Boone EC; Staggs VS; Pearce RE; Wang WY; Gaedigk R; Leeder JS; Gaedigk A
Clin Pharmacol Ther; 2022 Mar; 111(3):646-654. PubMed ID: 34716917
[TBL] [Abstract][Full Text] [Related]
8. Effect of CYP2D6, 2C19, and 3A4 Phenoconversion in Drug-Related Deaths.
Aly SM; Hennart B; Gaulier JM; Allorge D
Toxics; 2024 Mar; 12(4):. PubMed ID: 38668482
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
10. Metabolic ratios and SNPs implicated in tramadol-related deaths.
Aly SM; Hakim F; Richeval C; Hennart B; Gaulier JM; Allorge D
Int J Legal Med; 2023 Sep; 137(5):1431-1437. PubMed ID: 37460702
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study.
Magarbeh L; Gorbovskaya I; Wells R; Jhirad R; Le Foll B; Müller DJ
J Pers Med; 2023 May; 13(6):. PubMed ID: 37373907
[TBL] [Abstract][Full Text] [Related]
12. An Investigation of O-Demethyl Tramadol/Tramadol Ratio for Cytochrome P450 2D6 Phenotyping: The CYTRAM Study.
De La Gastine B; Percevault S; Varin L; Richard N; Fobe F; Plaud B; Daccache G; Compere V; Parienti JJ; Coquerel A; Loilier M; Bleyzac N; Bourguignon L; Goutelle S; Lelong-Boulouard V
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297612
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics and Forensic Toxicology: A New Step towards a Multidisciplinary Approach.
Di Nunno N; Esposito M; Argo A; Salerno M; Sessa F
Toxics; 2021 Nov; 9(11):. PubMed ID: 34822683
[TBL] [Abstract][Full Text] [Related]
14. Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?
Gusella M; Pasini F; Corso B; Bertolaso L; De Rosa G; Falci C; Modena Y; Barile C; Da Corte Z D; Fraccon A; Toso S; Cretella E; Brunello A; Modonesi C; Segati R; Oliani C; Minicuci N; Padrini R;
Pharmacol Res Perspect; 2020 Oct; 8(5):e00646. PubMed ID: 32813313
[TBL] [Abstract][Full Text] [Related]
15. Heart insufficiency after combination of verapamil and metoprolol: A fatal case report and literature review.
Saedder EA; Thomsen AH; Hasselstrøm JB; Jornil JR
Clin Case Rep; 2019 Nov; 7(11):2042-2048. PubMed ID: 31788248
[TBL] [Abstract][Full Text] [Related]
16. A pathway-driven predictive model of tramadol pharmacogenetics.
Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
Eur J Hum Genet; 2019 Jul; 27(7):1143-1156. PubMed ID: 30824817
[TBL] [Abstract][Full Text] [Related]
17. Increasing the reach of forensic genetics with massively parallel sequencing.
Budowle B; Schmedes SE; Wendt FR
Forensic Sci Med Pathol; 2017 Sep; 13(3):342-349. PubMed ID: 28631109
[TBL] [Abstract][Full Text] [Related]
18. Back to the Future - Part 2. Post-mortem assessment and evolutionary role of the bio-medicolegal sciences.
Ferrara SD; Cecchetto G; Cecchi R; Favretto D; Grabherr S; Ishikawa T; Kondo T; Montisci M; Pfeiffer H; Bonati MR; Shokry D; Vennemann M; Bajanowski T
Int J Legal Med; 2017 Jul; 131(4):1085-1101. PubMed ID: 28444439
[TBL] [Abstract][Full Text] [Related]
19. Global genetic variation of select opiate metabolism genes in self-reported healthy individuals.
Wendt FR; Pathak G; Sajantila A; Chakraborty R; Budowle B
Pharmacogenomics J; 2018 Apr; 18(2):281-294. PubMed ID: 28398354
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
